CANSINO BIOLOGICS INC revenue breakdown overview

CANSINO BIOLOGICS INC revenue for the last year amounted to 877.96 M HKD, the most of which — 867.75 M HKD — came from its highest performing source at the moment, Vaccine and Related Products. The greatest contribution to the revenue figure was made by China — last year it brought CANSINO BIOLOGICS INC 862.13 M HKD, and the year before that — 377.94 M HKD.